IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women
Public ClinicalTrials.gov record NCT00955968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
IMPAACT 1077HS: HAART Standard Version of the Promoting Maternal and Infant Survival Everywhere (PROMISE) Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study was a randomized strategy trial conducted among women who received highly active antiretroviral therapy (HAART) during pregnancy for purposes of prevention of mother-to-child transmission (PMTCT) of HIV but did not otherwise meet criteria to initiate HAART for their own health. The study was designed to determine whether continuation of HAART after delivery or other pregnancy outcome reduced morbidity and mortality compared to discontinuation and re-initiation of HAART when protocol specified criteria were met.
Study identification
- NCT ID
- NCT00955968
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,653 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1, 2010 (Actual)
- Primary completion
- Aug 31, 2016 (Actual)
- Completion
- Aug 31, 2016 (Actual)
- Last update posted
- Aug 14, 2023
2010 – 2016
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California MCA Center (5048) | Alhambra | California | 90007 | — |
| David Geffen School of Medicine at UCLA (5112) | Los Angeles | California | 90095 | — |
| UCSD Mother-Child-Adolescent HIV Program (4601) | San Diego | California | 92093 | — |
| Harbor (UCLA) Medical Center (5045) | Torrance | California | 90505 | — |
| University of Colorado (5052) | Aurora | Colorado | 80045 | — |
| Howard University (5044) | Washington D.C. | District of Columbia | 20059 | — |
| Georgetown University (1008) | Washington D.C. | District of Columbia | — | — |
| Washington Hospital Center (5023) | Washington D.C. | District of Columbia | — | — |
| Children's Diagnostic and Treatment Center (5055) | Fort Lauderdale | Florida | — | — |
| University of Florida at Jacksonville (5051) | Jacksonville | Florida | — | — |
| University of Miami Pediatric/Perinatal Clinical Research Site (4201) | Miami | Florida | — | — |
| University of South Florida at Tampa (5018) | Tampa | Florida | — | — |
| Ann & Robert H Lurie Children's Hospital of Chicago (4001) | Chicago | Illinois | — | — |
| Tulane University (5095) | New Orleans | Louisiana | — | — |
| Johns Hopkins University School of Medicine (5092) | Baltimore | Maryland | 21287 | — |
| Boston Medical Center (5011) | Boston | Massachusetts | — | — |
| Wayne State University/Children's Hospital of Michigan (5041) | Detroit | Michigan | — | — |
| Metropolitan Hospital (5003) | New York | New York | 10029 | — |
| SUNY Stony Brook University Medical Center (5040) | Stony Brook | New York | — | — |
| Bronx-Lebanon Hospital Center (5114) | The Bronx | New York | — | — |
| Jacobi Medical Center (5013) | The Bronx | New York | — | — |
| Duke University Medical Center (4701) | Durham | North Carolina | — | — |
| Pitt CRS (1001) | Pittsburgh | Pennsylvania | 15213 | — |
| St Jude Children's Research Hospital (6501) | Memphis | Tennessee | — | — |
| Baylor College of Medicine Texas Children's Hospital (3801) | Houston | Texas | — | — |
| Seattle Children's Hospital (5017) | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00955968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2023 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00955968 live on ClinicalTrials.gov.